Neuropace, Inc. · NASDAQ:NPCE

Morrell Martha had 335 Neuropace, Inc. shares withheld for tax (Form 4)

Traded Jun 24, 2026 · Filed Jun 25, 2026

On Jun 24, 2026, Morrell Martha (CHIEF MEDICAL OFFICER) had 335 Neuropace, Inc. shares withheld for tax at US$16.22 for US$5,434, leaving 52,050 shares. Filed Jun 25, 2026 (Form 4).

Withheld for tax
335 shares
Price
US$16.22
Value
US$5,434
Holding after
52,050 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 24, 2026Common StockShares withheld for tax335US$16.2252,050Direct

Source

View original at SEC

Related